Kiniksa Pharmaceuticals Ltd (KNSA)
17.62
-0.24
(-1.37%)
USD |
NASDAQ |
Apr 25, 16:00
17.62
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals Price to Book Value: 2.834 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 2.874 |
| April 23, 2024 | 2.845 |
| April 22, 2024 | 2.751 |
| April 19, 2024 | 2.721 |
| April 18, 2024 | 2.716 |
| April 17, 2024 | 2.728 |
| April 16, 2024 | 2.810 |
| April 15, 2024 | 2.806 |
| April 12, 2024 | 2.782 |
| April 11, 2024 | 2.848 |
| April 10, 2024 | 2.808 |
| April 09, 2024 | 2.853 |
| April 08, 2024 | 2.845 |
| April 05, 2024 | 2.880 |
| April 04, 2024 | 2.906 |
| April 03, 2024 | 2.935 |
| April 02, 2024 | 3.014 |
| April 01, 2024 | 3.17 |
| March 28, 2024 | 3.175 |
| March 27, 2024 | 3.217 |
| March 26, 2024 | 3.213 |
| March 25, 2024 | 3.212 |
| March 22, 2024 | 3.213 |
| March 21, 2024 | 3.186 |
| March 20, 2024 | 3.183 |
| Date | Value |
|---|---|
| March 19, 2024 | 3.17 |
| March 18, 2024 | 3.151 |
| March 15, 2024 | 3.217 |
| March 14, 2024 | 3.275 |
| March 13, 2024 | 3.292 |
| March 12, 2024 | 3.289 |
| March 11, 2024 | 3.273 |
| March 08, 2024 | 3.349 |
| March 07, 2024 | 3.421 |
| March 06, 2024 | 3.379 |
| March 05, 2024 | 3.247 |
| March 04, 2024 | 3.249 |
| March 01, 2024 | 3.498 |
| February 29, 2024 | 3.402 |
| February 28, 2024 | 3.276 |
| February 27, 2024 | 3.362 |
| February 26, 2024 | 3.244 |
| February 23, 2024 | 3.218 |
| February 22, 2024 | 3.166 |
| February 21, 2024 | 3.205 |
| February 20, 2024 | 3.198 |
| February 16, 2024 | 3.202 |
| February 15, 2024 | 3.238 |
| February 14, 2024 | 3.194 |
| February 13, 2024 | 3.189 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.141
Minimum
Oct 18 2019
7.404
Maximum
Jun 29 2020
3.496
Average
3.374
Median
Sep 22 2021
Price to Book Value Benchmarks
| Amicus Therapeutics Inc | 18.77 |
| Geron Corp | 7.862 |
| United Therapeutics Corp | 1.856 |
| Vanda Pharmaceuticals Inc | 0.4736 |
| TG Therapeutics Inc | 13.38 |
Price to Book Value Related Metrics
| PE Ratio | 97.86 |
| PS Ratio | 4.716 |
| Price to Free Cash Flow | 96.76 |
| Price | 17.62 |
| Earnings Yield | 1.02% |
| Market Cap | 1.244B |
| Normalized PE Ratio | 97.86 |